In the wake of the introduction of the Overdose Prevention and Patient Safety (OPPS) Act, a bill that would amend the federal statute underlying the addiction treatment privacy regulations known as 42 CFR Part 2 (“Part 2”), ASAM has released a position statement. It was decided that the barriers that Part 2 currently presents to coordinated, safe, and high-quality medical care cause significant harm, and that thoughtful changes to the law are necessary to mitigate this harm while protecting patients’ privacy. Accordingly, ASAM joined other provider associations, patient groups, and health plans to support the OPPS Act, which would align Part 2 with HIPAA for the purposes of health care treatment, payment, and operations.

ASAM Position Statement

Free ASAM Webinar on the 42 CFR Part-2 Confidentiality Rule